Guangzhou Huateng Biomedical Technology Co., Ltd.
PrivateLast Round
Series B
Extension
Jan 1, 2026
Company Overview
Guangzhou Huateng Biomedical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series B Extension round in January 2026.
Guangzhou Huateng Biomedical Technology Co., Ltd. is a biotechnology company that provides preclinical contract research organization (CRO) services, including animal model development, drug efficacy testing, and safety evaluation for pharmaceutical and medical device companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Huateng Biomedical Technology Co., Ltd. Comparables
Compare Guangzhou Huateng Biomedical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xiamen Sinopeg Biotech Co., Ltd. | 89% | |
| BroadPharm | 87% | |
| Biopharma PEG Scientific Inc. | 86% |
For institutional investors. Book with your work email.
Guangzhou Huateng Biomedical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 1, 2026 | ||||
| Series B | Sep 21, 2024 | ||||
| Series A Extension | Aug 30, 2023 | ||||
| Series A | Sep 1, 2022 | ||||
| Angel | May 1, 2021 |
For institutional investors. Book with your work email.
Guangzhou Huateng Biomedical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Environmental Protection Foundation | Angel |
| Guangzhou Financial Holdings Fund Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Completed a Series B Extension funding round.
- Sep 21, 2024
Raised Series B round with Guangzhou Financial Holdings Fund Management.
For institutional investors. Book with your work email.
Guangzhou Huateng Biomedical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangzhou Huateng Biomedical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Huateng Biomedical Technology Co., Ltd. a public or private company?
Guangzhou Huateng Biomedical Technology Co., Ltd. is a private company.
What is the current stock price of Guangzhou Huateng Biomedical Technology Co., Ltd.?
Guangzhou Huateng Biomedical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Guangzhou Huateng Biomedical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangzhou Huateng Biomedical Technology Co., Ltd. worth (valuation)?
Valuation information for Guangzhou Huateng Biomedical Technology Co., Ltd. is not publicly available.
Can I buy Guangzhou Huateng Biomedical Technology Co., Ltd. stock?
Guangzhou Huateng Biomedical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangzhou Huateng Biomedical Technology Co., Ltd.'s last funding round?
Guangzhou Huateng Biomedical Technology Co., Ltd.'s most recent funding round was Series B Extension on January 1, 2026.
Who are the main investors in Guangzhou Huateng Biomedical Technology Co., Ltd.?
Key investors in Guangzhou Huateng Biomedical Technology Co., Ltd. include China Environmental Protection Foundation, Guangzhou Financial Holdings Fund Management.
Will Guangzhou Huateng Biomedical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Huateng Biomedical Technology Co., Ltd..
How can I track Guangzhou Huateng Biomedical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Guangzhou Huateng Biomedical Technology Co., Ltd.'s shares on secondary markets.